Kayitalire Louis 4
4 · F-star Therapeutics, Inc. · Filed Mar 11, 2021
Insider Transaction Report
Form 4
Kayitalire Louis
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2021-03-09+12,880→ 40,169 totalExercise: $7.24Exp: 2031-03-09→ Common Stock (12,880 underlying)
Footnotes (2)
- [F1]These options were granted under the Issuer's 2015 Equity Incentive Plan.
- [F2]Twenty five percent (25%) of the total number of shares under the award shall vest on the first anniversary of the Vesting Commencement Date, March 9, 2021, and thereafter in equal monthly installments over the remaining three years.